Shionogi

Jump to

Lupin resumes US sales of diabetes drug Fortamet copy

Drug maker Lupin said on Thursday that it has resumed US sales of its copy of Shionogi Inc's Fortamet tablets, a type 2 diabetes treatment drug.
Lupin's generic Fortamet launch suffers setback in US

A US district court in New Jersey has granted motion for a preliminary injunction against Lupin's generic version of anti-diabetes drug Fortamet.
Lupin hopeful of getting Fortamet case through

Lupin had launched Fortamet, a diabetic drug, at risk in the US, causing an injunction against the drug. Chief Financial Officer S Ramesh clarified that Fortamet generic was launched only for few days.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Shionogi

Lupin resumes US sales of diabetes drug Fortamet copy

Lupin's generic Fortamet launch suffers setback in US

Lupin hopeful of getting Fortamet case through